Liver transplantation (LTx) for liver cirrhosis caused by hepatitis C virus is increasing in recent years. The problem of LTx for cirrhosis due to hepatitis C is the reactivation of hepatitis C virus after transplantation. Approximately 50-60% of patients will develop chronic active hepatitis within one year after transplantation. In addition, 20% of those patients develop liver cirrhosis within five years. Unlike hepatitis B, recurrent hepatitis C is usually mild and is characterized by gradual progress. On the other hand, fibrosing cholestatic hepatitis (FCH), a specific histologic manifestation of hepatitis B virus infection, is characterized by periportal fibrosis, hepatocyte ballooning, cholestasis and relatively scant inflammation. FCH will rapidly progress to liver cirrhosis for a short period of time. In recent years, FCH has been increasingly reported to occur after LTx for hepatitis C cirrhosis. Herein, we report a case of FCH after living-donor LTx for hepatitis C, which led to a rapid graft loss on POD 233.